TLDR Pig blood can be used to mass-produce stable, low-cost platelet dry powder for medical use.
The study developed a method for industrial mass production of platelet dry powder from pig blood, achieving a platelet concentration 15 times higher than whole blood using calcium chloride as an activator. Different calcium chloride concentrations affected growth factor levels, with 20% yielding the highest TGF-β1 and 10% the highest PDGF-BB. The powder maintained over 90% of its initial TGF-β1 concentration after 12 months, demonstrating long-term stability. The method is cost-effective, environmentally friendly, and offers a reliable supply for regenerative medicine and tissue engineering. The process showed high reproducibility across six batches, confirming its stability and repeatability.
60 citations
,
December 2021 in “Cytokine & growth factor reviews” PRP therapy shows promise in healing and tissue repair across various medical fields but needs more research for standardization and optimization.
1 citations
,
April 2018 in “Journal of Investigative Dermatology” People respond differently to hair loss treatment with PRP because of individual differences in growth factors from platelets.
348 citations
,
July 2017 in “Skin appendage disorders” Platelet-rich plasma shows promise for skin and hair treatments but needs more research and standardization.
18 citations
,
February 2024 in “ACS Polymers Au” Silk fibroin shows promise for wound care but faces challenges in becoming widely available.
12 citations
,
September 2020 in “Nanomaterials” The new drug delivery system improves vitiligo treatment by enhancing melanocyte activity and viability.
169 citations
,
October 2020 in “Pharmaceutics” Polysaccharide-based nanofibers are promising for better wound healing.
49 citations
,
January 2017 in “Oxidative Medicine and Cellular Longevity” Eclipta alba extract may help fight cancer and has antioxidant benefits without being toxic.
51 citations
,
March 2019 in “Journal of cellular physiology” Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.